TNF and inflammatory bowel disease: Current treatments for human IBD include aminosalicylic acid, glucocorticoids, immunosuppressants, and tumor necrosis factor (TNF)-α inhibitors, but nearly 30% of patients do not respond to these treatments and 50% of patients become refractory over time (1, 2).